PUT/EVOTEC/20/0.1/21.06.24 Share Price

Warrant

DE000GK9HX30

Real-time BOERSE MUENCHEN 12:31:05 13/06/2024 pm IST
1.116 EUR +0.90% Intraday chart for PUT/EVOTEC/20/0.1/21.06.24
Current month-4.41%
1 month+5.33%
Date Price Change
13/24/13 1.116 +0.90%
12/24/12 1.106 -1.07%
11/24/11 1.118 -1.58%
10/24/10 1.136 +1.52%
07/24/07 1.119 +0.90%

Real-time BOERSE MUENCHEN

Last update June 13, 2024 at 12:31 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying EVOTEC SE
Issuer Goldman Sachs
WKN GK9HX3
ISINDE000GK9HX30
Date issued 24/08/2022
Strike 20
Maturity 21/06/2024 (9 Days)
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.179
Lowest since issue 0.165
Spread 0.01
Spread %0.90%

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
8.97 EUR
Average target price
20.79 EUR
Spread / Average Target
+131.77%
Consensus